Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers

dc.contributor.author	Birkenfeld, Andreas L.
dc.date.accessioned	2022-06-24T09:11:13Z
dc.date.available	2022-06-24T09:11:13Z
dc.date.issued	2021
dc.identifier.issn	1432-0428
dc.identifier.uri	http://hdl.handle.net/10900/128391
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00125-021-05562-9
dc.subject.ddc	610	de_DE
dc.title	Rivaroxaban compared with low-dose aspirin in individuals with type 2 diabetes and high cardiovascular risk: a randomised trial to assess effects on endothelial function, platelet activation and vascular biomarkers	de_DE
dc.type	Article	de_DE
utue.quellen.id	20211125174918_00671
utue.publikation.seiten	2701-2712	de_DE
utue.personen.roh	Pistrosch, Frank
utue.personen.roh	Matschke, Jan B.
utue.personen.roh	Schipp, Dorothea
utue.personen.roh	Schipp, Bernhard
utue.personen.roh	Henkel, Elena
utue.personen.roh	Weigmann, Ingo
utue.personen.roh	Sradnick, Jan
utue.personen.roh	Bornstein, Stefan R.
utue.personen.roh	Birkenfeld, Andreas L.
utue.personen.roh	Hanefeld, Markolf
dcterms.isPartOf.ZSTitelID	Diabetologia	de_DE
dcterms.isPartOf.ZS-Issue	12	de_DE
dcterms.isPartOf.ZS-Volume	64	de_DE
utue.fakultaet	04 Medizinische Fakultät
utue.fakultaet	Sonstige

Files in this item

Files	Size	Format	View
There are no files associated with this item.